4108927566_c42e335fbd_z

First case of Ebola recorded in Uganda

June 12, 2019
Research and Development

Ebola has spread to Uganda, according to the WHO. A five year old boy has been infected with the Ebola …

vertex-headquarters

MPs discuss breaking Vertex’s IP rights to bring Orkambi to UK

June 11, 2019
Research and Development Orkambi, Vertex, access, house of commons, pharma, pricing

MPs yesterday discussed circumventing Vertex’s patent on cystic fibrosis medicine Orkambi (Lumacaftor/ivacaftor) as a means of breaking the deadlock and …

astrazeneca_building_white

AstraZeneca’s Phase 3 Farxiga data impresses in type 2 diabetes

June 11, 2019
Manufacturing and Production, Research and Development AstraZeneca, diabetes, farxiga, pharma, type 2 diabetes

AstraZeneca has presented new Phase 3 data at the American Diabetes Association (ADA) 79th Scientific Sessions in San Francisco on …

lilly_building_with_american_flag_web

Eli Lilly’s heart drug underwhelms with REWIND trial

June 11, 2019
Manufacturing and Production Eli Lilly, Trulicity, pharma

Eli Lilly’s Trulicity (dulaglutide) reduced major cardiovascular events (MACE) by 12% versus placebo in adults with type 2 diabetes, according …

inside_aryogen

Three workers killed by explosion at pharma factory in India

June 11, 2019
Manufacturing and Production China, India, explosion, manufacturing, pharma

Three engineers have been killed in an explosion at a manufacturing facility in India. Two Chinese engineers and one Indian …

Roche scores FDA approval for Polivy combo in diffuse large B-cell lymphoma

June 11, 2019
Manufacturing and Production, Sales and Marketing Polivy, Roche, lymphoma, pharma

Roche is celebrating the decision taken by the FDA to approve its anti-CD79b antibody-drug conjugate Polivy (polatuzumab vedotin-piiq) in combination …

Insys Therapeutics files for bankruptcy

June 11, 2019
Manufacturing and Production DoJ, Subsys, bankruptcy, insys, pharma

Opioid drugmaker Insys Therapeutics has filed for Chapter 11 bankruptcy protection after agreeing to pay $225 million to settle charges …

paul-hudson-big-image

Novartis Pharma head to become new Sanofi CEO

June 10, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Paul Hudson, appointment, olivier brandicourt

French drugmaker Sanofi has revealed that its CEO Olivier Brandicourt is to retire from the role, to be replaced with …

shutterstock_273326141

MSD scoops up biopharma firm Tilos for $773 million

June 10, 2019
Sales and Marketing MSD, Tilos Therapeutics, acquisition, pharma

US-based firm MSD has announced it intends to acquire biopharma firm Tilos Therapeutics, and has signed a deal with the …

Sanofi’s Soliqua proves superior to GLP-1 RA therapies in reducing blood sugar levels

June 10, 2019
Research and Development, Sales and Marketing Sanofi, Soliqua, diabetes, pharma, type 2 diabetes

Sanofi has stepped up at the American Diabetes Association (ADA) 79th Scientific Sessions in San Francisco, revealing new data which …

Novo’s oral semaglutide tops Jardiance and Victoza in two type 2 diabetes trials

June 10, 2019
Research and Development, Sales and Marketing Novo Nordisk, diabetes, pharma, semaglutide, type 2 diabetes

Novo Nordisk has taken the opportunity at the American Diabetes Association (ADA) 79th Scientific Sessions to pull back the curtain …

fda2outsideweb

FDA advisory panel backs TB Alliance’s tuberculosis regimen

June 10, 2019
Sales and Marketing FDA, TB Alliance, US, pharma, tuberculosis

An FDA advisory panel has voted to recommend the investigational drug pretomanid, developed by the non-profit organisation TB Alliance, as …

ward_lilley

Vectura CEO to step down at end of June

June 10, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, pharma, vectura

Vectura is on course for a new leader to take up the company’s reins after it was revealed that CEO …

Implementing “the safest medicines system in the world”

June 10, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, packaging, pharma

With debates heating up over cooperation between European across the continent, Matt Fellows investigates the current state of packaging countermeasures …

mercier

Long-term BMS exec Johanna Mercier joins Gilead as new Chief Commercial Officer

June 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma

Gilead Sciences have said Bristol-Myers Squibb exec Johanna Mercier will be the firm’s new Chief Commercial Officer. In her new …

paul-hudson-big-image

Novartis Pharma head to become new Sanofi CEO

June 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Paul Hudson, Sanofi, appointment, olivier brandicourt, pharma

French drugmaker Sanofi has revealed that its CEO Olivier Brandicourt is to retire from the role, to be replaced with …

marie-france_tschudin

Marie-France Tschudin, head of Novartis subsidiary AAA, takes over from Paul Hudson as Novartis Pharma CEO

June 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novartis has said Marie-France Tschudin will take over from Paul Hudson as the head of Novartis Pharmaceuticals. The announcement comes …

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

June 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, EMA, Janssen, Orkambi, Pfizer

It was revealed this week that Pfizer suppressed findings that their anti-inflammatory Enbrel reduced the risk of Alzheimer’s by 64%. …

Mallinckrodt illegally inflated price of drug from $50 to $32,000, DoJ lawsuit says

June 7, 2019
Business Services Achthar, DoJ, Mallinckrodt, Medicare, co-pay, pharma

The Department of Justice (DoJ) has filed new charges against Mallinckrodt alleging the Irish-listed firm illegally hiked the price of …

Otsuka to take over Astellas’ Cefixime business

June 7, 2019
Medical Communications APIs, Antibiotics, Astellas, Otsuka, antimicrobial, pharma

Japanese firm Otsuka Chemical has bought Astellas Pharma’s antibiotic Cefixime. The agreement gives Otsuka the right to sell Cefixime and …

The Gateway to Local Adoption Series

Latest content